You are here: All Products  > Harbour BioMed Out-licenses Bispecific to AstraZeneca in $350 Million Agreement

Harbour BioMed Out-licenses Bispecific to AstraZeneca in $350 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products